Reminder: Exelixis Announces December 5 Webcast of Its Third Annu... ( SOUTH SAN FRANCISCO Calif. Nov. 2...)

Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day

Date:11/28/2007

SOUTH SAN FRANCISCO, Calif., Nov. 28 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) announced today that it will hold its Third Annual R&D Day on Wednesday, December 5, 2007 from 10:00 a.m. ET / 7:00 a.m. PT to 2:00 p.m. ET / 11:00 a.m. PT in New York. The company will discuss updates to its development pipeline, its collaborations, including those with GSK, BMS and Genentech, and its financial outlook for 2007.

Speakers:

-- George Scangos, PhD, President & Chief Executive Officer of Exelixis,

Inc.

-- Michael Morrissey, PhD, President of Research & Development of

Exelixis, Inc.

-- Frank Karbe, Executive Vice President & Chief Financial Officer of

Exelixis, Inc.

-- Peter Lamb, PhD, Senior Vice President, Discovery Research & Chief

Scientific Officer of Exelixis, Inc.

-- Gisela Schwab, MD, Senior Vice President and Chief Medical Officer of

Exelixis, Inc.

-- Steven Sherman, MD of MD Anderson Cancer Center

-- Vince Miller, MD of Memorial Sloan-Kettering Cancer Center

The event will be webcast and may be accessed in the Event Calendar page under Investors at http://www.exelixis.com.

An archive of this webcast will be available until 9:00 p.m. PT/12:00 a.m. ET on January 4, 2008. Access numbers for this replay are: 1-888-286-8010 (domestic) and 1-617-801-6888 (international); the replay passcode number is: 21270665.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Reminder: XTL to Hold a Conference Call Today at 8:30 am EDT to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
2. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
3. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
4. Exelixis Announces Closing of Public Offering of Common Stock
5. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
6. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
7. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
8. Exelixis Sells 80% Stake in Artemis to Taconic
9. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
10. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
11. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference

Post Your Comments:

(Date:12/4/2008)... MedImmune today announced that,it...s with chronic asthma to,determine the safety of ...body,(MAb) that targets the interleukin-5 recepto...ng the IL-5R pathway may lead to a targeted approa...continued study of this antibody. , "Asthma...

(Date:12/4/2008)...ew Trade Name Onrigin(TM) for Laromustine , ,... -- VION PHARMACEUTICALS, INC. (OTC Bulletin Boar... to events in connection with the 50th American So...Center in San Francisco from December 6-9, 2008. ... The Company announced that it would present surv...

(Date:12/4/2008).... 4 Based on its recent analysis o...an recognizes Honeywell Enraf with the 2008 Global...well Enraf,s comprehensive suite of blending produ...els, chemicals and other materials, but also minim...nraf,s blending equipment,s accuracy, ease of conf...

(Date:12/4/2008)...ire-FirstCall/ -- ExonHit Therapeutics S.A.,(Alte...pany, is pleased to,announce today that it has be...dustrial Property) during the last edition of its ... "Since its inception, ExonHit consistently ... of its intellectual property and in particular fr...

Breaking Biology Technology:MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 2 MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 3 Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2 Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3 Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4 Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support 2 Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support 3 ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 2 ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 3

[0] MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor [0] Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting [0] Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support [0] ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI)

...f Commerce has announced that it is producing the ...gies and Device Symposium on Thursday, September 2... 2810 Golf Road, in Pewaukee. , ,Wisconsins medic...in growing the economy of our state, said Departme...s. This presentation will help businesses identify...

... can share the details of the products that will b...to trust me that this is an exciting lot of produc...ence, it,s not too late. See below for details.) ,...ith you two new products I discovered last week wh...rs Conference in Boise. (I know, you,re thinking: ...

...on to be deployed to the South Pole to help an int...- including many from the Space Science and Engine...n - to build a neutrino telescope known as IceCube...iences Laboratory (PSL). , ,To build IceCube, eng... of bowling ball-sized photomultiplier tubes (PMTs...

... planning to open a new state-of-art healthcare fa...ital will include the latest in digital imaging te...ents and physicians will benefit from enterprise s...across its integrated delivery network (IDN). , ,...ally recognized leader in efforts to improve the q...

Other Biology Technology:Medical Technologies and Devices Symposium 2 Two Cool Products Advance Printing Capabilities 2 Aurora Selects New Imaging Technology 2

Medical Technologies and Devices Symposium Two Cool Products Advance Printing Capabilities IceCube Drilling Rig Aurora Selects New Imaging Technology

(Date:12/4/2008)...aped people who carry weight in the thighs and bac...gh blood pressure and heart disease than apple-sha...indings from nutrition researchers at Washington U...body-shape comparisons don,t completely explain ri...at appears to be the real key to insulin resistanc...

(Date:12/4/2008)...akes and destructive tsunamis over the past four y...large earthquake, warns an international group of ... the Dec. 4 issue of the journal Nature . , The...e 9.2 in December 2004, produced the most widespre...cause of that calamity was the rupture of a 1600-k...

(Date:12/4/2008)... will be published by Springer as of January 2009...Fisheries Science, previously published by Wiley-B...lication of basic and applied research articles in...ies science. , Published in English six times a...eview articles covering a wide array of topics in ...

(Date:12/3/2008)... the site today, it,s easy to forget that a dam an...consin-Madison,s Franbrook Farm Research Station i...ure are gone, and acres of plants, both native and..., Nevertheless, memories of the dam remain, and ... researchers are now unearthing them. Writing in a...

[0] Apple or pear shape is not main culprit to heart woes -- it's liver fat [0] September 2007 Sumatran earthquakes research findings [0] Springer to publish Fisheries Science as of 2009 [0] Researchers examine role of soil patterns in dam restoration

...things, are among the most studied molecules in bi...ld" from sequenced strings of amino acids has long... common belief holds that the more proteins are co...less likely to unfold - they become. Now, as repor... Journal, a team of chemical and biological engine...

...ture in this kind of article , A detailed struct...n activating the Epstein Barr Virus in human cells...ean Molecular Biology Laboratory (EMBL) and the In...MS), associated with the Université Joseph Fourier..., the Epstein Barr Virus (EBV) slumbers in the cel...

...tre have uncovered a gene that could help to devel... with the changing world climate. Researchers fund...search Council (BBSRC) at the John Innes Centre in...ontrols how the plant responds to seasonal changes...nding how plants have adapted their flowering beha...

...al avian flu conference last fall believe there is...anufacture and stockpile enough vaccine or antivir...he virus mutate into a form that can be spread eas... by researchers at Carnegie Mellon University. The...ne 2006 issue of the journal Global Public Health....

Other Biology News:UW-Madison engineers squeeze secrets from proteins 2 Waking a sleeping virus 2 Growing crops to cope with climate change 2 Medical experts: US unlikely to have enough vaccines to stop avian flu 2

UW-Madison engineers squeeze secrets from proteins Waking a sleeping virus Growing crops to cope with climate change Medical experts: US unlikely to have enough vaccines to stop avian flu

...an 18 amino acid synthetic peptide whose sequence ... sequence of this peptide is (amino to carboxy ter... P - R - D - A - A - D - Q - N(18). This peptide...ments with the polyclonal antibody that reacts wit...

Rabbit polyclonal antibody to Glutathione-S-Transferase (GST)

...In Vitro Osteogenesis Assay Kit contains all reage...1cells to a mature osteoblastic lineage, as determ...his kit provides all the necessary reagents and a ...dard plate reader. This product is useful for stud...

...d of discovery races ever faster, you need a partn...ant focus is on providing tools and solutions to h... 3000 Laboratory Automation Workstation offers a l... flexible. By integrating all aspects of liquid ha...

Biology Products:

Rat rab 3D Neutralizing Peptide from ABR-Affinity BioReagents Rabbit Anti-GST Polyclonal Antibody, Unconjugated from Novus Biologicals In Vitro Osteogenesis Assay Kit from CHEMICON Biomek 3000 Laboratory Automation Workstation from Beckman Coulter

Reminder: Exelixis Announces December 5 Webcast of Its Third Annu...( SOUTH SAN FRANCISCO Calif. Nov. 2...)